Loading clinical trials...
Loading clinical trials...
Trabectedin and Irinotecan in Pediatric Refractory Sarcomas
Conditions
Interventions
Combined chemotherapy with trabectedin followed by irinotecan
Start Date
February 1, 2014
Primary Completion Date
July 1, 2016
Completion Date
July 1, 2017
Last Updated
July 27, 2015
NCT04851119
NCT02243605
NCT03155620
NCT01552434
NCT00536601
NCT01614795
Lead Sponsor
Technical University of Munich
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions